Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7626070rdf:typepubmed:Citationlld:pubmed
pubmed-article:7626070lifeskim:mentionsumls-concept:C0023903lld:lifeskim
pubmed-article:7626070lifeskim:mentionsumls-concept:C0242606lld:lifeskim
pubmed-article:7626070lifeskim:mentionsumls-concept:C0041370lld:lifeskim
pubmed-article:7626070lifeskim:mentionsumls-concept:C1551336lld:lifeskim
pubmed-article:7626070lifeskim:mentionsumls-concept:C0079411lld:lifeskim
pubmed-article:7626070lifeskim:mentionsumls-concept:C0060239lld:lifeskim
pubmed-article:7626070pubmed:issue2lld:pubmed
pubmed-article:7626070pubmed:dateCreated1995-8-31lld:pubmed
pubmed-article:7626070pubmed:abstractTextFe-NTA is a known renal carcinogen. However, little is known about its carcinogenic potential in liver. In this study we for the first time show that Fe-NTA is a potent hepatic tumor promoter. Fe-NTA administration induced dose dependently the hepatic ornithine decarboxylase (ODC) activity several folds as compared to its activity in the saline-treated rats. Similarly, hepatic DNA synthesis which is measured as [3H]thymidine incorporation in DNA is also increased following Fe-NTA treatment. The effects of Fe-NTA were similar to other tumor promoters not only with respect to inducing ODC activity and [3H]thymidine incorporation in DNA but also in depleting antioxidant armory of the tissue. Fe-NTA depleted levels of glutathione to about 35% of the saline-treated control and activities of antioxidant enzymes catalase, glutathione peroxidase, glutathione reductase and glucose 6-phosphate dehydrogenase decreased significantly (45-55% of saline-treated control). Concomitant with the depletion in antioxidant armory, Fe-NTA augmented hepatic microsomal lipid peroxidation more than three folds. The pretreatment of rats with antioxidants BHA or BHT diminished the observed effects of Fe-NTA. Our data indicate that Fe-NTA is a potent hepatic tumor promoter and acts through a mechanism involving oxidative stress.lld:pubmed
pubmed-article:7626070pubmed:languageenglld:pubmed
pubmed-article:7626070pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7626070pubmed:citationSubsetIMlld:pubmed
pubmed-article:7626070pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7626070pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7626070pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7626070pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7626070pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7626070pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7626070pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7626070pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7626070pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7626070pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7626070pubmed:statusMEDLINElld:pubmed
pubmed-article:7626070pubmed:monthJullld:pubmed
pubmed-article:7626070pubmed:issn0006-291Xlld:pubmed
pubmed-article:7626070pubmed:authorpubmed-author:IqbalMMlld:pubmed
pubmed-article:7626070pubmed:authorpubmed-author:AtharMMlld:pubmed
pubmed-article:7626070pubmed:authorpubmed-author:GiriUUlld:pubmed
pubmed-article:7626070pubmed:issnTypePrintlld:pubmed
pubmed-article:7626070pubmed:day17lld:pubmed
pubmed-article:7626070pubmed:volume212lld:pubmed
pubmed-article:7626070pubmed:ownerNLMlld:pubmed
pubmed-article:7626070pubmed:authorsCompleteYlld:pubmed
pubmed-article:7626070pubmed:pagination557-63lld:pubmed
pubmed-article:7626070pubmed:dateRevised2005-11-17lld:pubmed
pubmed-article:7626070pubmed:meshHeadingpubmed-meshheading:7626070-...lld:pubmed
pubmed-article:7626070pubmed:meshHeadingpubmed-meshheading:7626070-...lld:pubmed
pubmed-article:7626070pubmed:meshHeadingpubmed-meshheading:7626070-...lld:pubmed
pubmed-article:7626070pubmed:meshHeadingpubmed-meshheading:7626070-...lld:pubmed
pubmed-article:7626070pubmed:meshHeadingpubmed-meshheading:7626070-...lld:pubmed
pubmed-article:7626070pubmed:meshHeadingpubmed-meshheading:7626070-...lld:pubmed
pubmed-article:7626070pubmed:meshHeadingpubmed-meshheading:7626070-...lld:pubmed
pubmed-article:7626070pubmed:meshHeadingpubmed-meshheading:7626070-...lld:pubmed
pubmed-article:7626070pubmed:meshHeadingpubmed-meshheading:7626070-...lld:pubmed
pubmed-article:7626070pubmed:meshHeadingpubmed-meshheading:7626070-...lld:pubmed
pubmed-article:7626070pubmed:meshHeadingpubmed-meshheading:7626070-...lld:pubmed
pubmed-article:7626070pubmed:meshHeadingpubmed-meshheading:7626070-...lld:pubmed
pubmed-article:7626070pubmed:meshHeadingpubmed-meshheading:7626070-...lld:pubmed
pubmed-article:7626070pubmed:meshHeadingpubmed-meshheading:7626070-...lld:pubmed
pubmed-article:7626070pubmed:meshHeadingpubmed-meshheading:7626070-...lld:pubmed
pubmed-article:7626070pubmed:meshHeadingpubmed-meshheading:7626070-...lld:pubmed
pubmed-article:7626070pubmed:meshHeadingpubmed-meshheading:7626070-...lld:pubmed
pubmed-article:7626070pubmed:meshHeadingpubmed-meshheading:7626070-...lld:pubmed
pubmed-article:7626070pubmed:meshHeadingpubmed-meshheading:7626070-...lld:pubmed
pubmed-article:7626070pubmed:year1995lld:pubmed
pubmed-article:7626070pubmed:articleTitleFerric nitrilotriacetate (Fe-NTA) is a potent hepatic tumor promoter and acts through the generation of oxidative stress.lld:pubmed
pubmed-article:7626070pubmed:affiliationDepartment of Medical Elementology and Toxicology, Hamdard University, New Delhi, India.lld:pubmed
pubmed-article:7626070pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7626070lld:pubmed